Co-morbid potentiality of Acquired TB MDR patients in RSUD DR. Soetomo

Mirza Mahendra Putra 1, *, Ni Made Mertaniasih 2, 4, Ariani Permatasari 3, 4 and Arief Bakhtiar 3, 4

1 Medical Study Program, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia.
2 Department of Medical Microbiology, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia.
3 Department of Pulmonology and Respirology, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia.
4 Dr Soetomo General Academic Hospital, Surabaya, Indonesia.
 
Research Article
World Journal of Advanced Research and Reviews, 2023, 20(03), 1021–1024
Article DOI: 10.30574/wjarr.2023.20.3.2512
 
Publication history: 
Received on 31 October 2023; revised on 11 December 2023; accepted on 14 December 2023
 
Abstract: 
Tuberculosis or TB is a global problem because of it high number globally. The 2021 WHO report shows that in 2020 there were around 9.9 million TB cases of which 1.2 million died. Of the total cases, 465,000 were MDR/RR-TB case. In Indonesia, TB RO is estimated to reach 2.4% of the total new TB patients and 13% of TB patients who have been treated previously. In the Global Tuberculosis Report issued by WHO in 2023, there were 28,000 cases of MDR-TB in Indonesia. TB patients with Diabetes Mellitus (DM) also have a 6.8x risk of being infected with secondary MDR-TB. This research is an observational study conducted retrospectively using medical records obtained from the MDR-TB polyclinic in Dr Soetomo General Academic Hospital during the period January 2019 to January 2023. The result of the highest co-morbid was DM with 29.3% MDR-TB Patients are found with DM with 47.7% cause of infection are treatment failure.
 
Keywords: 
MDR-TB Comorbid; HIV and MDR-TB; Hypertension among MDR-TB
 
Full text article in PDF: 
 
Copyright information: 
Copyright © 2023 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0

 

Share this